Single User License
INR 96420
Site License
INR 192840
Corporate User License
INR 289260

Service Tax Additional

select a format

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Thrombotargets Europe SL-Product Pipeline Review-2015

Thrombotargets Europe SL-Product Pipeline Review-2015

  • Products Id :- GMDHC07227CDB
  • |
  • Pages: 24
  • |
  • June 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Thrombotargets Europe SL-Product Pipeline Review-2015


Global Markets Direct's, 'Thrombotargets Europe SL-Product Pipeline Review-2015', provides an overview of the Thrombotargets Europe SL 's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Thrombotargets Europe SL 's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Thrombotargets Europe SL including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Thrombotargets Europe SL 's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Thrombotargets Europe SL 's pipeline products

Reasons To Buy

Evaluate Thrombotargets Europe SL 's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Thrombotargets Europe SL in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Thrombotargets Europe SL 's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Thrombotargets Europe SL and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Thrombotargets Europe SL

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Thrombotargets Europe SL and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Thrombotargets Europe SL Snapshot 5

Thrombotargets Europe SL Overview 5

Key Information 5

Key Facts 5

Thrombotargets Europe SL-Research and Development Overview 6

Key Therapeutic Areas 6

Thrombotargets Europe SL-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Thrombotargets Europe SL-Pipeline Products Glance 10

Thrombotargets Europe SL-Clinical Stage Pipeline Products 10

Phase II Products/Combination Treatment Modalities 10

Thrombotargets Europe SL-Early Stage Pipeline Products 11

Preclinical Products/Combination Treatment Modalities 11

Discovery Products/Combination Treatment Modalities 12

Thrombotargets Europe SL-Drug Profiles 13

TT-173 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

TT-105 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

TT-111 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

TT-112 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

TT-120 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

Thrombotargets Europe SL-Pipeline Analysis 18

Thrombotargets Europe SL-Pipeline Products by Route of Administration 18

Thrombotargets Europe SL-Pipeline Products by Molecule Type 19

Thrombotargets Europe SL-Recent Pipeline Updates 20

Thrombotargets Europe SL-Dormant Projects 21

Thrombotargets Europe SL-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Appendix 23

Methodology 23

Coverage 23

Secondary Research 23

Primary Research 23

Expert Panel Validation 23

Contact Us 23

Disclaimer 24

List of Tables

Thrombotargets Europe SL, Key Information 5

Thrombotargets Europe SL, Key Facts 5

Thrombotargets Europe SL-Pipeline by Indication, 2015 7

Thrombotargets Europe SL-Pipeline by Stage of Development, 2015 8

Thrombotargets Europe SL-Monotherapy Products in Pipeline, 2015 9

Thrombotargets Europe SL-Phase II, 2015 10

Thrombotargets Europe SL-Preclinical, 2015 11

Thrombotargets Europe SL-Discovery, 2015 12

Thrombotargets Europe SL-Pipeline by Route of Administration, 2015 18

Thrombotargets Europe SL-Pipeline by Molecule Type, 2015 19

Thrombotargets Europe SL-Recent Pipeline Updates, 2015 20

Thrombotargets Europe SL-Dormant Developmental Projects,2015 21

Thrombotargets Europe SL, Other Locations 22

Thrombotargets Europe SL, Subsidiaries 22

List of Figures

Thrombotargets Europe SL-Pipeline by Top 10 Indication, 2015 7

Thrombotargets Europe SL-Pipeline by Stage of Development, 2015 8

Thrombotargets Europe SL-Monotherapy Products in Pipeline, 2015 9

Thrombotargets Europe SL-Pipeline by Top 10 Molecule Type, 2015 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Thrombotargets Europe SL ; Thrombotargets Europe SL - Key Therapeutics; Thrombotargets Europe SL - Pipeline Overview and Promising Molecules; Thrombotargets Europe SL - News; Thrombotargets Europe SL - Latest Updates; Thrombotargets Europe SL - Pipeline; Thrombotargets Europe SL - Discontinued/Dormant Projects

Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]